Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Mar 03, 2021 3:47pm
63 Views
Post# 32707517

RE:RE:RE:RE:RE:RE:Strong volume - big interest early m

RE:RE:RE:RE:RE:RE:Strong volume - big interest early m
schocor wrote:
porksniffer wrote:
EbbFlow88 wrote: I calculated cash and equivalents at around $3/share. So, you're getting GBT at $2. There is definitely weakness in currency exchange but I agree regarding value. Just will need to be patient with this one. At this price though, it's a great bet.



Reading this is dam insulting. People have been in this piece of garbage for 6 years and have been decimated. I tip my hat to the CEO and our management for turning this debacle into the worse performing company in the country the past 1, 3, 5 years. Again, people need to appreciate how difficult it is to be the worst at anything....


I am sure he didn't mean to insult you - but I highly doubt he cares that you are insulted. Why not 1> Sell if you are not happy with the management 2> Buy more if you think it is cheap? I bought some last week, and then, I BOUGHT MORE TODAY. Can't you do the same? I am not suggesting you are poor, but you do seem like the sensitive type so I will apologize if my message on an internet stock board has insulted you further.


First off, 'dam insulting' doesn't refer to me, more in general and was hyperbole. That means not to be taken literally. I would think the tone of my posts should tell you I'm anything but sensitive.

I would never average down in a garbage stock like this. Everyone who has opined the same nonsense as "I bought more today",  including a certain regular big mouth on this forum who will remain nameless, has been crushed and added to their losses. Everyone here is so confident this will work has been wrong for 6 years now. Don't forget the CEO is a billionaire who self admits he got 'lucky'. Why should he be motivated? Not a single press releases in a year. ZERO.

This has now become a measly spec on my portfolio, pretty much the only one of over a dozen holdings. Adding another cent here is laughable. This will become a solid tax loss as that is it's only value.
<< Previous
Bullboard Posts
Next >>